DevLife Bioscience

Devlife Corporation is an integrated pharmaceutical company headquartered in Mumbai, India, specializing in the development, manufacturing, and international marketing of high-quality pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). Since its inception in 2005, the company has established a significant presence in the generic drugs sector, operating WHO GMP-certified manufacturing facilities in Gujarat that produce a variety of dosage forms including tablets, capsules, soft gels, and injectables. Their therapeutic focus encompasses infectious diseases, analgesics, anti-malarials, and cardiovascular health, with a product portfolio exported to over 30 countries across Latin America, Southeast Asia, and Africa. In 2020, the group expanded its footprint through the incorporation of Devlife Therapeutics to enhance its manufacturing and R&D capabilities. The company maintains a 'Customer First' philosophy, providing both branded generics and third-party contract manufacturing services.